Showing results (191-200 of 408) with videos related to
Sort By:
Pageof 41
Scandinavian Journal of Gastroenterology|November 15, 2006
Chronic cyclooxygenase blockade enhances the vasopressin responsiveness in collaterals of portal hypertensive ratsHui-Chun Huang, Sun-Sang Wang, Yi-Chou Chen, et al.Journal of Clinical Gastroenterology|August 2, 2007
Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosisYing-Wen Wang, Teh-Ia Huo, Ying-Ying Yang, et al.Shock (Augusta, Ga.)|March 20, 2009
Evolution of portal-systemic collateral vasopressin response in endotoxemic portal hypertensive ratsHui-Chun Huang, Sun-Sang Wang, Ching-Chih Chang, et al.Clinical Science (London, England : 1979)|July 24, 2013
Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injuryYing-Ying Yang, Pei-Chang Lee, Yi-Tsau Huang, et al.Clinical Transplantation|March 6, 2008
Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapyTeh-Ia Huo, Yi-Hsiang Huang, Chien-Wei Su, et al.Hepatology International|July 24, 2015
Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinomaYun-Hsuan Lee, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.Annals of Surgical Oncology|December 11, 2014
Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic ResectionChien-Wei Su, Gar-Yang Chau, Hung-Hsu Hung, et al.Journal of Clinical Gastroenterology|January 6, 2010
Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiencyChia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, et al.Plos One|March 5, 2015
Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?Chia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.Journal of Clinical Gastroenterology|February 25, 2015
Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score AnalysisChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.Pageof 41